The Health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An evidence review and research agenda. Washington, National Academies Press, 2017.
However, cannabidiol as an anxiety reducer has almost none of these issues. One study had 24 participants who took either 600 mg of CBD or a placebo drug. In a speaking test that followed, the group which underwent CBD treatment showed less anxiety. They also had a smaller degree of cognitive impairment and felt less discomfort overall as they spoke. In other words, their results were better than those of the placebo group.
Thapa, D., Toguri, J. T., Szczesniak, A. M., & Kelly, A. E. M. (2017, April 1). The non-psychoactive phytocannabinoid, cannabidiol (CBD), and the synthetic derivatives, HU308 and CBD-DMH, reduces hyperalgesia and inflammation in a mouse model of corneal injury [Abstract]. FASEB Journal. Retrieved from https://www.fasebj.org/doi/abs/10.1096/fasebj.31.1_supplement.811.7
CBD has positive implications in a vast number of illnesses and has been shown to boost general health, hair and skin. Research isn’t conclusive here, although it is strong, and in the coming years, we are expecting to see more and more evidence. THC, on the other hand, can benefit other disorders but comes with drawbacks, such as the feelings of being high and possible induction of feelings of anxiety and paranoia and more.
This is a whole new idea to me and I can use any help you can offer. I suffer from post stroke pain in my thigh which sounds similar to the pain diabetics feel in their feet (sort of electric shocks shooting through my skin). I’ve had this 24/7 for about 5 years now. The 600 mg Gabapentin 3 times a day is no longer helping. A friend just suggested marijuana topicals which I had never heard of! Any recommendations?
Due to its anti-inflammatory properties, CBD oil has recently become a wellness-world darling, popping up in everything from mascara to bath bombs. But the science hasn’t caught up to the supply. A 2017 University of Pennsylvania study found “a lack of regulation and oversight” on cannabidiol extracts, and that 70 percent of CBD products sold online were mislabeled. So like many other products we consume or put on our skin daily (makeup, lotions, supplements, vitamins) none of it is regulated. If you live in a state where marijuana is not recreationally legal, your CBD will most likely be derived from hemp. And that’s okay, says Leivent. “Hemp-based CBD still works on the same issues like anxiety and anti-inflammatory conditions, there are just fewer amounts of the other chemicals that could enhance the effect of the CBD."
In the United States, the CBD drug Epidiolex has been approved by the Food and Drug Administration for treatment of two epilepsy disorders. The U.S. Drug Enforcement Administration has assigned Epidiolex a Schedule V classification while non-Epidiolex CBD remains a Schedule I drug prohibited for any use. CBD is not scheduled under any United Nations drug control treaties, and in 2018 the World Health Organization recommended that it remain unscheduled.
Not only that, but the growing conditions for hemp aren’t federally regulated, which makes it very difficult to know when you’re getting a high quality, clean, and safe product. Knowing the growing conditions of the soil, overall environment, and extraction methods is going to be crucial when hemp-based CBD oils become legal, because it’s been known to absorb toxic spills, pesticides, and other dangerous chemicals that you don’t want to be ingesting.
Every field of interest comes with its own terminology. In the world of CBD, it can seem like there are many terms that are being thrown out there, such as CBD oil, hemp oil, THC oil, cannabis oil, and marijuana oil. With the vast amount of information being introduced, it is easy to confuse one term from the next. We have received numerous questions in regards to the difference between all of these terms.
CBD oil derived from whole-plant marijuana has seen promising results for numerous medical treatments, including treating children with epilepsy. (In 2013, CNN’s Dr. Sanjay Gupta introduced the world to a child who after using CBD oil went from having 300 seizures a month to only two.) On April 19, the AP reported that an FDA panel is reviewing a a pharmaceutical-grade CBD oil made from whole-plant marijuana called Epidiolex, a possible treatment for rare forms of pediatric epilepsy. If approved, it would be the first marijuana-made medication sold on the U.S. market. A day later, on the marijuana community’s “high holiday,” April 20, New York Senator Chuck Schumer introduced legislation to decriminalize marijuana on the federal level. Forecasters are predicting that legal cannabis in the U.S. will be outselling soda by 2030.
As an alternative health regimen, CBD holds particular appeal to women, said Gretchen Lidicker, the health editor of Mindbodygreen, a wellness website based in New York, and the author of “CBD Oil Everyday Secrets.” Noting the preponderance of female-run CBD businesses, Ms. Lidicker, 26, said that it is “no surprise that women are leading the CBD movement.”
Despite this, CBD is something nobody knows much about, and certainly nobody is monitoring it properly. CBD is widely marketed as a supplement, despite the Food and Drug Administration saying it does not qualify as such (this is because it is an active ingredient in drugs which are either approved or under investigation to be approved). CBD goes largely unregulated by the agency; on the FDA’s FAQ page, a vague answer maintains there are “many factors in deciding whether or not to initiate an enforcement action.” The Department of Agriculture handles research grants and pilot programs for hemp, but that’s where its involvement ends.